The company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments. The company expects to receive approximately $7.5 million (approximately $8.7 million if the underwriter’s over-allotment option is exercised in full) in gross proceeds from the offering, which is subject to closing conditions.